Daxor Corp (NASDAQ:DXR)
| Market Cap | 60.72M-20.5% |
| Revenue (ttm) | 154.87K+161.9% |
| Net Income | 6.23M+42.3% |
| EPS | 1.23+118.6% |
| Shares Out | 5.84M |
| PE Ratio | 8.29 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Jan 5, 2018 |
| Volume | 2,515.904 |
| Open | 10.67 |
| Previous Close | 10.51 |
| Day's Range | 10.17 - 10.67 |
| 52-Week Range | 8.56 - 14.76 |
| Beta | 0.26 |
| Analysts | Buy |
| Price Target | 23.00(+121.15%) |
| Earnings Date | Mar 10, 2027 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About DXR
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$DXR stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in DXR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by DXR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
DXR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New DXR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to DXR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in DXR
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $505.89K |
Estimated from each fund’s disclosed top holdings × AUM
DXR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from DXR’s recent data — informational, not investment advice